Brookstone Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
19,260
+3,231
+20% +$180K 0.01% 676
2026
Q2
$872K Sell
16,029
-5,129
-24% -$250K 0.01% 741
2026
Q1
$907K Buy
21,158
+5,076
+32% +$218K 0.01% 677
2025
Q4
$705K Buy
16,082
+66
+0.4% +$2.73K 0.01% 741
2025
Q3
$661K Buy
+16,016
New +$644K 0.01% 734

Other funds holding EXEL

Brookstone Capital Management's EXEL Position: Q3 2026 in Review

Brookstone Capital Management increased its Exelixis (EXEL) stake by 20% in Q3 2026, buying an estimated $180K and bringing the position to 19,260 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #676.

Brookstone Capital Management first reported a position in EXEL in Q3 2025 and has held it in 5 quarters since. 381 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Brookstone Capital Management held 19,260 shares of Exelixis worth $1.12M as of Q3 2026.
  • Brookstone Capital Management bought 3,231 Exelixis shares in Q3 2026, an estimated $180K.
  • Exelixis made up 0.01% of Brookstone Capital Management's portfolio in Q3 2026, its #676 holding.
  • Brookstone Capital Management first reported a position in Exelixis in Q3 2025 and has held it in 5 quarters since.
  • 381 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.